Cargando…
Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
SIMPLE SUMMARY: The expression of Euchromatin histone lysine methyltransferase 1 and 2 (EHMT1/2) is deregulated in many cancers. Most studies thus far have focused on the downstream targets and pathways regulated by EHMTs. However, the mechanisms that lead to their deregulated expression, and the in...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221123/ https://www.ncbi.nlm.nih.gov/pubmed/35740522 http://dx.doi.org/10.3390/cancers14122855 |